1. Infarct Zone: a Novel Platform for Exosome Trade in Cardiac Tissue Regeneration
- Author
-
Finosh G. Thankam and Devendra K. Agrawal
- Subjects
0301 basic medicine ,Myocardial Infarction ,Pharmaceutical Science ,030204 cardiovascular system & hematology ,Exosomes ,Regenerative Medicine ,Bioinformatics ,Exosome ,Extracellular vesicles ,Article ,Cardiac regeneration ,03 medical and health sciences ,0302 clinical medicine ,Tissue engineering ,Genetics ,Animals ,Humans ,Regeneration ,Medicine ,Myocardial infarction ,Genetics (clinical) ,Tissue Engineering ,business.industry ,Myocardium ,Recovery of Function ,medicine.disease ,Microvesicles ,030104 developmental biology ,cardiovascular system ,Molecular Medicine ,Artery diseases ,Cardiology and Cardiovascular Medicine ,business ,Infarct zone - Abstract
The global incidence of coronary artery diseases (CADs), especially myocardial infarction (MI), has drastically increased in recent years. Even though the conventional therapies have improved the outcomes, the post-MI complications and the increased rate of recurrence among the survivors are still alarming. Molecular events associated with the pathogenesis and the adaptive responses of the surviving myocardium are largely unknown. Focus on exosome-mediated signaling for cell-cell/matrix communications at the infarct zone reflects an emerging opportunity in cardiac regeneration. Also, cardiac tissue engineering provides promising insights for the next generation of therapeutic approaches in the management of CADs. In this article, we critically reviewed the current understanding on the biology of cardiac exosomes, therapeutic potential of exosomes, and recent developments in cardiac tissue engineering and discussed novel translational approaches based on tissue engineering and exosomes for cardiac regeneration and CADs.
- Published
- 2020